@daveg - If this wasn’t the case for Clarity IMHO the current valuation is probably unjustified simply based on trial results. My guess is the valuation has more short term (transaction within 1 year) expectation built into it than pure valuation assigned to future revenues/ profits based on positive trials.
AIMO.
CU6 - ASX Charts, page-330
-
- There are more pages in this discussion • 421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.13 |
Change
-0.170(2.70%) |
Mkt cap ! $1.910B | |||
| Open | High | Low | Value | Volume |
| $6.32 | $6.48 | $6.11 | $5.556M | 885.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.20 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |